Dr. Ben Derman discusses his research on MRD2STOP study, which explores whether patients can safely stop maintenance therapy after achieving deep remission. His findings suggest that MRD negativity at the ten-to-the-minus-six level is a strong indicator of long-term remission, and ongoing research could help identify patients who might be functionally cured.

Link to ASH playlist: [ Ссылка ]

ASH Abstract: Clonotypic Peptide Mass Spectrometry to Define Functional Cure in Patients with Multiple Myeloma Undergoing Maintenance Cessation
#ASH24 #myeloma #mmsm
Follow HealthTree: [ Ссылка ]
twitter.com/healthtreeformm
facebook.com/healthtreeformultiplemyeloma
instragram.com/healthtreeformultiplemyeloma

свернуть